Practical overview
When it fits
Consider it when you want a self-deployed diabetes platform for supported device or Nightscout data and can evaluate its alpha-stage software and device-specific qualifications. Its suggestions are intended to accompany professional medical care.
Who it is for
- People managing diabetes who want to view supported glucose and therapy data with AI-generated supplementary analysis.
- Developers and self-hosters interested in deploying or extending an open-source diabetes platform.
Documented uses
- Monitor data from supported continuous glucose monitors and insulin devices.
- Review daily AI briefs and detected patterns in diabetes-related data.
- Ask questions through conversational AI chat.
- Add AI analysis to data from an existing Nightscout instance.
- Configure an AI provider and choose whether inference runs locally or through a cloud service.
Requirements & limits
- AI provider choice determines whether health data stays on user-controlled infrastructure or is transmitted to a third-party cloud provider.
- Device status varies: some integrations are verified, while Tandem Mobi is unverified on hardware and Medtronic 700-series data mapping has unverified areas.
- The platform is alpha software and the project says it has not been broadly tested.
- The web platform, Android app and Wear OS watch face occupy separate repositories; the mobile components are not part of the main repository's listed stack.
Check current requirements in the official documentation. Source-based guidance does not mean OpenViST has run or independently tested this project.
Start the platform locally with Docker Compose
Bring up the documented web interface and API for local development.
Before you start
- Git
- Docker Compose
Steps
Clone the GlycemicGPT repository.
Change into the repository directory.
Copy
.env.exampleto.env.Run the command below.
docker compose up --build -d
Expected outcome
The README lists the web UI at localhost:3000, the API at localhost:8000 and API documentation at localhost:8000/docs.
Guide limitations
- This quick start is described as a developer-oriented local setup.
- The project is identified as alpha software and has not been broadly tested.
Sources & review
Source record details
- Source availability
- Active
- Sources checked
- 12 October 2026
- Original website title
- lumose-health/GlycemicGPT · Official homepage title · retained in its source language

